Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger

Bingwen Eugene Fan; Christine Cheung

doi:10.1055/s-0041-1728717

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2022; 48(01): 112-114
DOI: 10.1055/s-0041-1728717

Letter to the Editor

Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger

Authors

Bingwen Eugene Fan

¹Department of Haematology, Tan Tock Seng Hospital, Singapore

²Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore

³Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

⁴Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Christine Cheung

³Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

⁵Institute of Molecular and Cell Biology, Singapore

Abstract

Full Text

References

References
1 Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost 2020; 46 (07) 763-771
2 Fan BE, Ng J, Chan SSW. et al. COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J Thromb Thrombolysis 2020; ; (epub ahead of print)
3 Late Sequelae of COVID-19. Updated November 13, 2020. Accessed March 25, 2021 at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html
4 COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188]. Accessed December 18 2020 at: https://www.nice.org.uk/guidance/ng188
5 Fan BE, Umapathi T, Chua K. et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis 2021; 51 (04) 971-977
6 Veyre F, Poulain-Veyre C, Esparcieux A. et al. Femoral arterial thrombosis in a young adult after nonsevere COVID-19. Ann Vasc Surg 2020; 69: 85-88
7 Schweblin C, Hachulla AL, Roffi M, Glauser F. Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report. Eur Heart J Case Rep 2020; 4 (06) 1-4
8 Del Nonno F, Colombo D, Nardacci R, Falasca L. Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization. Thromb J 2021; 19 (01) 1
9 Ranard LS, Engel DJ, Kirtane AJ, Masoumi A. Coronary and cerebral thrombosis in a young patient after mild COVID-19 illness: a case report. Eur Heart J Case Rep 2020; 4 (05) 1-5
10 Taquet M, Geddes JR, Husain M. et al. Six-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19. medRxiv 2021.01.16.21249950
11 von Meijenfeldt FA, Havervall S, Adelmeijer J. et al. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv 2021; 5 (03) 756-759
12 McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2020; 2 (07) e437-e445
13 Kwong JC, Schwartz KL, Campitelli MA. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018; 378 (26) 2540-2541
14 Lippi G, Sanchis-Gomar F. Cardiac troponin elevation in patients with influenza virus infections. Biomed J 2020; S2319-4170 (20)30088-3
15 McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 2021; 3 (03) e224-e233
16 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288
17 Colmenero I, Santonja C, Alonso-Riaño M. et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020; 183 (04) 729-737
18 Ackermann M, Verleden SE, Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020; 383 (02) 120-128
19 Chioh FW, Fong SW, Young BE. et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife 2021; 10: e64909
20 Lippi G, Henry B. How will emerging SARS-CoV-2 variants impact herd immunity?. SSRN 2021 https://ssrn.com/abstract=3791910
21 Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis 2020; 50 (03) 512-524
22 Dhawan RT, Gopalan D, Howard L. et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2021; 9 (01) 107-116
23 Pick JM, Wang S, Wagner-Lees S. et al. Coronary artery aneurysms are more common in post COVID-19 multisystem inflammatory syndrome in children (MIS-C) than pre-pandemic Kawasaki disease. November 17, 2020;142(Suppl 3): Abstracts From the American Heart Association's 2020 Scientific Sessions
24 Bikdeli B, Madhavan MV, Gupta A. et al; Global COVID-19 Thrombosis Collaborative Group. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost 2020; 120 (07) 1004-1024